Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1546 | 2517 | 31.4 | 70% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2517 | 3370 | FEBRILE NEUTROPENIA//NEUTROPENIA//SEGMENTED FILAMENTOUS BACTERIA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | FEBRILE NEUTROPENIA | Author keyword | 148 | 42% | 11% | 275 |
2 | NEUTROPENIA | Author keyword | 57 | 14% | 14% | 364 |
3 | NEUTROPENIC FEVER | Author keyword | 24 | 42% | 2% | 44 |
4 | FEVER AND NEUTROPENIA | Author keyword | 19 | 74% | 1% | 14 |
5 | FEVER IN NEUTROPENIA | Author keyword | 12 | 86% | 0% | 6 |
6 | MASCC SCORE | Author keyword | 9 | 83% | 0% | 5 |
7 | LOW RISK FEBRILE NEUTROPENIA | Author keyword | 8 | 100% | 0% | 5 |
8 | FLUOROQUINOLONE PROPHYLAXIS | Author keyword | 6 | 100% | 0% | 4 |
9 | IMMUNOCOMPROMISED HOST DIS UNIT | Address | 6 | 100% | 0% | 4 |
10 | PIPERACILLIN TAZOBACTAM | Author keyword | 5 | 16% | 1% | 29 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FEBRILE NEUTROPENIA | 148 | 42% | 11% | 275 | Search FEBRILE+NEUTROPENIA | Search FEBRILE+NEUTROPENIA |
2 | NEUTROPENIA | 57 | 14% | 14% | 364 | Search NEUTROPENIA | Search NEUTROPENIA |
3 | NEUTROPENIC FEVER | 24 | 42% | 2% | 44 | Search NEUTROPENIC+FEVER | Search NEUTROPENIC+FEVER |
4 | FEVER AND NEUTROPENIA | 19 | 74% | 1% | 14 | Search FEVER+AND+NEUTROPENIA | Search FEVER+AND+NEUTROPENIA |
5 | FEVER IN NEUTROPENIA | 12 | 86% | 0% | 6 | Search FEVER+IN+NEUTROPENIA | Search FEVER+IN+NEUTROPENIA |
6 | MASCC SCORE | 9 | 83% | 0% | 5 | Search MASCC+SCORE | Search MASCC+SCORE |
7 | LOW RISK FEBRILE NEUTROPENIA | 8 | 100% | 0% | 5 | Search LOW+RISK+FEBRILE+NEUTROPENIA | Search LOW+RISK+FEBRILE+NEUTROPENIA |
8 | FLUOROQUINOLONE PROPHYLAXIS | 6 | 100% | 0% | 4 | Search FLUOROQUINOLONE+PROPHYLAXIS | Search FLUOROQUINOLONE+PROPHYLAXIS |
9 | PIPERACILLIN TAZOBACTAM | 5 | 16% | 1% | 29 | Search PIPERACILLIN+TAZOBACTAM | Search PIPERACILLIN+TAZOBACTAM |
10 | ANTIBACTERIAL PROPHYLAXIS | 5 | 47% | 0% | 8 | Search ANTIBACTERIAL+PROPHYLAXIS | Search ANTIBACTERIAL+PROPHYLAXIS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GRANULOCYTOPENIC PATIENTS | 237 | 72% | 7% | 186 |
2 | CEFTAZIDIME PLUS AMIKACIN | 164 | 82% | 4% | 94 |
3 | EMPIRIC THERAPY | 113 | 71% | 4% | 91 |
4 | MULTINATIONAL ASSOCIATION | 87 | 79% | 2% | 56 |
5 | PLUS AMIKACIN | 79 | 88% | 1% | 37 |
6 | EARLY HOSPITAL DISCHARGE | 69 | 61% | 3% | 73 |
7 | LOW RISK NEUTROPENIA | 51 | 91% | 1% | 21 |
8 | NEUTROPENIC PATIENTS | 49 | 17% | 11% | 269 |
9 | FEBRILE NEUTROPENIA | 48 | 25% | 7% | 166 |
10 | GRANULOCYTOPENIC CANCER PATIENTS | 46 | 67% | 2% | 42 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer | 2002 | 1046 | 145 | 64% |
1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever | 1997 | 414 | 160 | 75% |
Meta-analysis: Antibiotic prophylaxis reduces mortality in neutropenic patients | 2005 | 192 | 94 | 94% |
Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance | 2013 | 34 | 48 | 58% |
GUIDELINES FOR THE USE OF ANTIMICROBIAL AGENTS IN NEUTROPENIC PATIENTS WITH UNEXPLAINED FEVER | 1990 | 357 | 116 | 81% |
MANAGEMENT OF FEVER IN PATIENTS WITH CANCER AND TREATMENT-INDUCED NEUTROPENIA | 1993 | 593 | 88 | 34% |
Effect of quinolone prophylaxis in afebrile neutropenic patients on microbial resistance: systematic review and meta-analysis | 2007 | 43 | 51 | 98% |
Antibiotic prophylaxis in neutropenic patients - New evidence, practical decisions | 2006 | 68 | 37 | 76% |
Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO) | 2013 | 18 | 58 | 59% |
The current spectrum of infection in cancer patients with chemotherapy related neutropenia | 2014 | 8 | 54 | 41% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | IMMUNOCOMPROMISED HOST DIS UNIT | 6 | 100% | 0.2% | 4 |
2 | REIPI SPANISH NETWORK INFECT DIS | 3 | 50% | 0.2% | 4 |
3 | MANITOBA BLOOD MARROW TRANSPLANT PROGRAMME | 3 | 60% | 0.1% | 3 |
4 | PEDIAT ADOLESCENT COMPARAT EFFECTIVENESS | 2 | 67% | 0.1% | 2 |
5 | PROGRAM MICROBIOL MYCOL | 2 | 67% | 0.1% | 2 |
6 | PROGRAM POPULAT GENOM | 1 | 31% | 0.2% | 4 |
7 | CIBE INVEST BIOMED RED ENFERMEDADES P | 1 | 100% | 0.1% | 2 |
8 | IMMUNOCOMPROMISED HOST PROGRAM | 1 | 100% | 0.1% | 2 |
9 | INVEST CLIN H TAGNON | 1 | 50% | 0.1% | 2 |
10 | MED KLIN POLIKLIN ONKOL HAMATOL | 1 | 100% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000119865 | PEGFILGRASTIM//FEBRILE NEUTROPENIA//FILGRASTIM |
2 | 0.0000080503 | GRANULOCYTE TRANSFUSION//GRANULOCYTE TRANSFUSIONS//GRANULOCYTE CONCENTRATES |
3 | 0.0000070785 | TRANSPLANT RATES//EBMT ACT SURVEY OFF//OPERAT COMPUTAT FINANCE |
4 | 0.0000063789 | ABT VIRALE TRANSFORMAT MECHANISMEN//AUSTRALIAN MEDICINAL PLANTS//CELLULAR AUTONOMY |
5 | 0.0000061294 | ASPERGILLOSIS//INVASIVE ASPERGILLOSIS//INVASIVE PULMONARY ASPERGILLOSIS |
6 | 0.0000060299 | NEUTROPENIA RECOVERY//TRATAMENTO INTENS//CRITICALLY ILL CANCER PATIENTS |
7 | 0.0000059631 | TYPHLITIS//NEUTROPENIC ENTEROCOLITIS//NEUTROPENIC COLITIS |
8 | 0.0000056375 | BUNDES INFEKT KRANKHEITEN NICHT UBERTRAGBAR//NEONATAL BACTERIAL INFECTION//PMEU |
9 | 0.0000047872 | CEFEPIME//CEFPIROME//FK037 |
10 | 0.0000047523 | SEGMENTED FILAMENTOUS BACTERIA//CANDIDATUS ARTHROMITUS//PUTREFACTIVE PRODUCTS |